Outcomes Matter Innovations Partners with Regional Cancer Care Associates to Launch Value-Based Care in Oncology
Outcomes Matter Innovations (OMI) announced a new partnership with Regional Cancer Care Associates (RCCA), the largest cancer care provider in New Jersey, to launch an Oncology Value-Based Care (VBC) Program. The collaboration aims to improve clinical outcomes and affordability in oncology by combining RCCA’s extensive network and expertise with OMI’s technology-driven approach to value-based care. RCCA operates 26 offices across New Jersey, Connecticut, Massachusetts, and the Washington, D.C. area, providing innovative cancer treatments and access to hundreds of clinical trials.
OMI’s VBC programs are designed to help payers and providers monitor and improve care quality in real time. The company manages the entire process—from identifying eligible patients to delivering insights at the point of care—while aligning incentives to reward better outcomes and more efficient care. Through this partnership, RCCA oncologists will have access to OMI’s technology platform and data analytics to support informed decision-making and reduce the overall cost of care.
Leaders from both organizations emphasized the transformative potential of the collaboration. Dr. Denis Fitzgerald of RCCA highlighted the opportunity to maintain high-quality outcomes while making cancer care more affordable, and Dr. Andrew Pecora, CEO and Chairman of OMI, described the partnership as an important step toward expanding value-based care across medical specialties.
OMI, founded in 2018 and based in New Jersey, continues to grow nationally, partnering with specialty physicians to embed clinical treatment pathways into its technology. The company plans to announce additional partnerships in the near future as it expands its mission to improve quality and affordability in specialty care through data-driven, value-based solutions.
Read press release here.